相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Brain propagation of transduced α-synuclein involves non-fibrillar protein species and is enhanced in α-synuclein null mice
Michael Helwig et al.
BRAIN (2016)
Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease
Nour K. Majbour et al.
MOLECULAR NEURODEGENERATION (2016)
Cerebrospinal Fluid Biomarkers in Alzheimer's and Parkinson's Diseases-From Pathophysiology to Clinical Practice
Kaj Blennow et al.
MOVEMENT DISORDERS (2016)
Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease
Sara Hall et al.
MOVEMENT DISORDERS (2016)
Oligomeropathies and Pathogenesis of Alzheimer and Parkinson's Diseases
Gianluigi Forloni et al.
MOVEMENT DISORDERS (2016)
Ginsenoside Rb1 inhibits fibrillation and toxicity of alpha-synuclein and disaggregates preformed fibrils
Mustafa T. Ardah et al.
NEUROBIOLOGY OF DISEASE (2015)
Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology
Nishant N. Vaikath et al.
NEUROBIOLOGY OF DISEASE (2015)
Phosphorylated α-synuclein in Parkinson's disease: correlation depends on disease severity
Tessandra Stewart et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2015)
Correlates of cerebrospinal fluid levels of oligomeric- and total-α-synuclein in premotor, motor and dementia stages of Parkinson's disease
Yaroslau Compta et al.
JOURNAL OF NEUROLOGY (2015)
CSF biomarkers and clinical progression of Parkinson disease
Sara Hall et al.
NEUROLOGY (2015)
Cerebrospinal Fluid α-Synuclein Predicts Cognitive Decline in Parkinson Disease Progression in the DATATOP Cohort
Tessandra Stewart et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Reduced α-synuclein levels in cerebrospinal fluid in Parkinson's disease are unrelated to clinical and imaging measures of disease severity
K. D. van Dijk et al.
EUROPEAN JOURNAL OF NEUROLOGY (2014)
Cerebrospinal Fluid Lysosomal Enzymes and Alpha-Synuclein in Parkinson's Disease
Lucilla Parnetti et al.
MOVEMENT DISORDERS (2014)
Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease
Oskar Hansson et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Structure activity relationship of phenolic acid inhibitors of α-synuclein fibril formation and toxicity
Mustafa T. Ardah et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease
Lucilla Parnetti et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
Cerebrospinal fluid biomarkers in Parkinson disease
Lucilla Parnetti et al.
NATURE REVIEWS NEUROLOGY (2013)
Differences in Brain Activation Between Tremor- and Nontremor-Dominant Parkinson Disease
Janey Prodoehl et al.
JAMA NEUROLOGY (2013)
Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI
Leslie M. Shaw et al.
ACTA NEUROPATHOLOGICA (2011)
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study (vol 10, pg 230, 2011)
B. Mollenhauer et al.
LANCET NEUROLOGY (2011)
The Relation Between Cognition and Motor Dysfunction in Drug-Naive Newly Diagnosed Patients with Parkinson's Disease
Magdalena Eriksson Domellof et al.
MOVEMENT DISORDERS (2011)
Cerebrospinal Fluid Tau/α-Synuclein Ratio in Parkinson's Disease and Degenerative Dementias
Lucilla Parnetti et al.
MOVEMENT DISORDERS (2011)
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study
Brit Mollenhauer et al.
LANCET NEUROLOGY (2011)
Parkinson's disease: clinical features and diagnosis
J. Jankovic
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Red blood cells are the major source of alpha-synuclein in blood
Robin Barbour et al.
NEURODEGENERATIVE DISEASES (2008)
Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease
Takahiko Tokuda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
α-Synuclein aggregation in neurodegenerative diseases and its inhibition as a potential therapeutic strategy
KE Paleologou et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2005)
分享论文
